Xiaohui He
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 52
- Oncology 39
- Viral-associated cancers and disorders 19
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Shengyu Zhou (64 shared papers)Yuankai Shi (55 shared papers)Jianliang Yang (56 shared papers)Liqiang Zhou (25 shared papers)Lin Gui (58 shared papers)Changgong Zhang (51 shared papers)Ye‐Xiong Li (11 shared papers)Shulian Wang (7 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Hematology (5 papers)Chinese Journal of Cancer (4 papers)Annals of Oncology (4 papers)Blood (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaohui He
119 papers receiving 1.9k citations
Xiaohui He's Hit Papers
Peers
Comparison fields: 5 of 102
- Otorhinolaryngology 224
- Pathology and Forensic Medicine 746
- Geriatrics and Gerontology 124
- Oncology 667
- Immunology 247
Countries citing papers authored by Xiaohui He
This map shows the geographic impact of Xiaohui He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui He more than expected).
Fields of papers citing papers by Xiaohui He
This network shows the impact of papers produced by Xiaohui He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui He. The network helps show where Xiaohui He may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohui He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials Hit paper breakdown → | 2018 | 336 |
| 2 | 2005 | 271 | |
| 3 | 2009 | 107 | |
| 4 | 2008 | 69 | |
| 5 | 2019 | 64 | |
| 6 | 2019 | 45 | |
| 7 | 2016 | 44 | |
| 8 | 2023 | 34 | |
| 9 | 2020 | 34 | |
| 10 | 2020 | 34 | |
| 11 | 2019 | 32 | |
| 12 | 2016 | 30 | |
| 13 | 2013 | 30 | |
| 14 | 2007 | 29 | |
| 15 | 2012 | 28 | |
| 16 | 2015 | 25 | |
| 17 | 2021 | 24 | |
| 18 | 2014 | 24 | |
| 19 | 2020 | 20 | |
| 20 | 2022 | 20 |
About Xiaohui He
Xiaohui He is a scholar working on Pathology and Forensic Medicine, Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 130 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (52 papers), Viral-associated cancers and disorders (19 papers), Head and Neck Cancer Studies (13 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers), Malaria Research and Control (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Otorhinolaryngology (224 citations), Pathology and Forensic Medicine (746 citations), Geriatrics and Gerontology (124 citations), Oncology (667 citations) and Immunology (247 citations). Xiaohui He has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shengyu Zhou, Yuankai Shi, Jianliang Yang, Liqiang Zhou, Lin Gui, Changgong Zhang, Ye‐Xiong Li, Shulian Wang, Weihu Wang and Yong-Wen Song. Their work appears in journals such as Journal of Clinical Oncology, Annals of Hematology, Chinese Journal of Cancer, Annals of Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.